跳至主要内容
临床试验/IRCT20180128038539N1
IRCT20180128038539N1已完成3 期

Evaluation of mycophenolate mofetil and prednisolone effect as initial treatment on idiopathic membranous nephropathy

Ahvaz University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients with nephrotic syndrome with more than 4 gr / d of proteins in 24-hour urine
  • changes in GFR by increase more than 30% without a known cause in serum creatinine level
  • patients with severe and disabling symptoms associated with nephrotic syndrome

排除标准

  • systemic disease
  • active infection
  • unstable angina pectoris
  • type I and type II diabetes
  • clinical evidence of renal vein thrombosis
  • acute gastric ulcer or gastrointestinal disease that disturbs the absorption of oral medications

研究者

相似试验

Evaluation of mycophenolate mofetil and prednisolone... | 临床试验